Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03266952 · ClinicalTrials.gov registry record

Stroke Incidence and Risk Factors in a Tri-ethnic Region

A clinical trial, sponsored by University of Miami.

Completed
Registry status
3,497
Enrollment target

NCT03266952 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 3,497 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03266952 has completed, sponsored by University of Miami.

COMPLETED
Registry status
3,497 participants
Enrollment target

Study Summary

Enrollment of a population-based, prospective cohort of 3298 stroke-free adults was completed in 2001 and annual follow-up has continued since then. This collaborative study is the first prospective cohort study among whites, blacks and Caribbean Hispanics living in the same community. This grant supports continued follow-up and outcome detection and expansion of data collection in this cohort. The aims are to evaluate the relationship between vascular outcomes (stroke, myocardial infarction (MI), and vascular death) and insulin resistance, carotid intima-media thickness, carotid distensibility, and quantitative magnetic resonance imaging (MRI) measures of vascular subclinical brain disease and to determine if MRI subclinical disease accounts for race/ethnic differences in cognitive impairment. To accomplish these aims further data collection using the population-based, prospective cohort study is proposed. Stored baseline serum will be used to measure fasting insulin levels to evaluate insulin resistance. High-resolution carotid imaging data will be collected at subsequent visits to expand the measurements of subclinical carotid disease to 1300 subjects. MRIs and a neuropsychological battery emphasizing frontal executive domains will be done on 1300 subjects and quantitative analyses performed to measure white matter hyperintensities, silent infarcts, and silent cerebral microbleeds. Starting in 2005, subjects enrolled in the MRI substudy began to have echocardiograms and 24hour ambulatory blood pressure monitoring. Subjects will be followed by annual telephone interviews to ascertain stroke, MI, death, and changes in cognitive state. In-person assessment will be done for all subjects who screen positive. Community stroke surveillance will be maintained to insure stroke detection among the cohort. Specific diagnostic committees classify stroke, MI and vascular death.

Trial Details

FieldValue
Enrollment Target 3,497 participants
Start Date 1993-01
Est. Completion 2022-12

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT03266952

The ClinicalTrials.gov registry entry for NCT03266952 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,497 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03266952 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03266952 about?

NCT03266952 is a clinical study titled "Stroke Incidence and Risk Factors in a Tri-ethnic Region". Enrollment of a population-based, prospective cohort of 3298 stroke-free adults was completed in 2001 and annual follow-up has continued since then. This collaborative study is the first prospective cohort study among whites, blacks and Caribbean Hispanics living in the same community. This grant su...

What is the current status of trial NCT03266952?

This trial is currently completed. The enrollment target is 3,497 participants. The study started on 1993-01. Estimated completion is 2022-12.

Who is sponsoring clinical trial NCT03266952?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.